Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inanovate

Inanovate
2006 FOUNDED
PRIVATE STATUS
PE Growth LATEST DEAL TYPE
5 FINANCING ROUNDS
Description

Developer of technology for the detection and measurement of multiple proteins intended to provide the Life Sciences industry with technology for screening and analyzing proteins. The company's operations include testing and benchmarking of Bio-ID which consists of a compact bench-top analyzer and disposable test cartridges that lowers the cost and improves the accuracy of diagnostic tests by rapidly and precisely measuring the concentration of multiple disease-related biological molecules from patient blood samples.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • 2329 North Career Avenue
  • Suite 113
  • Sioux Falls, SD 57107
  • United States

+1 (605) 000-0000

Inanovate Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Inanovate‘s full profile, request access.

Request full access to PitchBook

Inanovate Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Inanovate‘s full profile, request access.

Request full access to PitchBook

Inanovate Executive Team (4)

Name Title Board
Seat
Contact
Info
David Ure Co-Founder & Chief Executive Officer
Robert Nelson Chief Operating Officer
James Nelson Ph.D Chief Technology Officer
David Arslanian Co-Founder & Board Member

Inanovate Board Members (5)

Name Representing Role Since Contact
Info
00000 000000000 Inanovate Co-Founder & Board Member 000 0000
00000 0000 Self Board Member 000 0000
0000000 000000000 00 Self Board Member 000 0000
00000 000 Self Board Member 000 0000
00000 000000 Self Board Member 000 0000